Cargando…
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recomme...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273732/ https://www.ncbi.nlm.nih.gov/pubmed/21803747 http://dx.doi.org/10.1136/ard.2011.154179 |
_version_ | 1782222959710044160 |
---|---|
author | Haraoui, Boulos Smolen, Josef S Aletaha, Daniel Breedveld, Ferdinand C Burmester, Gerd Codreanu, Catalin Da Silva, José Pereira de Wit, Maarten Dougados, Maxime Durez, Patrick Emery, Paul Fonseca, João Eurico Gibofsky, Allan Gomez-Reino, Juan Graninger, Winfried Hamuryudan, Vedat Jannaut Peῆa, Maria José Kalden, Joachim Kvien, Tore K Laurindo, Ieda Martin-Mola, Emilio Montecucco, Carlomaurizio Santos Moreno, Pedro Pavelka, Karel Poor, Gyula Cardiel, Mario H Stanislawska-Biernat, Ewa Takeuchi, Tsutomu van der Heijde, Désirée |
author_facet | Haraoui, Boulos Smolen, Josef S Aletaha, Daniel Breedveld, Ferdinand C Burmester, Gerd Codreanu, Catalin Da Silva, José Pereira de Wit, Maarten Dougados, Maxime Durez, Patrick Emery, Paul Fonseca, João Eurico Gibofsky, Allan Gomez-Reino, Juan Graninger, Winfried Hamuryudan, Vedat Jannaut Peῆa, Maria José Kalden, Joachim Kvien, Tore K Laurindo, Ieda Martin-Mola, Emilio Montecucco, Carlomaurizio Santos Moreno, Pedro Pavelka, Karel Poor, Gyula Cardiel, Mario H Stanislawska-Biernat, Ewa Takeuchi, Tsutomu van der Heijde, Désirée |
author_sort | Haraoui, Boulos |
collection | PubMed |
description | AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. RESULTS: A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. CONCLUSION: The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice. |
format | Online Article Text |
id | pubmed-3273732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-32737322012-02-16 Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire Haraoui, Boulos Smolen, Josef S Aletaha, Daniel Breedveld, Ferdinand C Burmester, Gerd Codreanu, Catalin Da Silva, José Pereira de Wit, Maarten Dougados, Maxime Durez, Patrick Emery, Paul Fonseca, João Eurico Gibofsky, Allan Gomez-Reino, Juan Graninger, Winfried Hamuryudan, Vedat Jannaut Peῆa, Maria José Kalden, Joachim Kvien, Tore K Laurindo, Ieda Martin-Mola, Emilio Montecucco, Carlomaurizio Santos Moreno, Pedro Pavelka, Karel Poor, Gyula Cardiel, Mario H Stanislawska-Biernat, Ewa Takeuchi, Tsutomu van der Heijde, Désirée Ann Rheum Dis Clinical and Epidemiological Research AIM: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. METHODS: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered ‘never’ or ‘not very often’, they were asked whether they would change their practice according to the particular recommendation. RESULTS: A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were ‘always’ and ‘very often’. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. CONCLUSION: The results of this survey demonstrated great support of ‘Treating RA to Target’ recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice. BMJ Group 2011-07-29 /pmc/articles/PMC3273732/ /pubmed/21803747 http://dx.doi.org/10.1136/ard.2011.154179 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Clinical and Epidemiological Research Haraoui, Boulos Smolen, Josef S Aletaha, Daniel Breedveld, Ferdinand C Burmester, Gerd Codreanu, Catalin Da Silva, José Pereira de Wit, Maarten Dougados, Maxime Durez, Patrick Emery, Paul Fonseca, João Eurico Gibofsky, Allan Gomez-Reino, Juan Graninger, Winfried Hamuryudan, Vedat Jannaut Peῆa, Maria José Kalden, Joachim Kvien, Tore K Laurindo, Ieda Martin-Mola, Emilio Montecucco, Carlomaurizio Santos Moreno, Pedro Pavelka, Karel Poor, Gyula Cardiel, Mario H Stanislawska-Biernat, Ewa Takeuchi, Tsutomu van der Heijde, Désirée Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title | Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title_full | Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title_fullStr | Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title_full_unstemmed | Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title_short | Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire |
title_sort | treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire |
topic | Clinical and Epidemiological Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273732/ https://www.ncbi.nlm.nih.gov/pubmed/21803747 http://dx.doi.org/10.1136/ard.2011.154179 |
work_keys_str_mv | AT haraouiboulos treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT smolenjosefs treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT aletahadaniel treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT breedveldferdinandc treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT burmestergerd treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT codreanucatalin treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT dasilvajosepereira treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT dewitmaarten treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT dougadosmaxime treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT durezpatrick treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT emerypaul treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT fonsecajoaoeurico treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT gibofskyallan treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT gomezreinojuan treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT graningerwinfried treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT hamuryudanvedat treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT jannautpeēamariajose treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT kaldenjoachim treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT kvientorek treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT laurindoieda treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT martinmolaemilio treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT montecuccocarlomaurizio treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT santosmorenopedro treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT pavelkakarel treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT poorgyula treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT cardielmarioh treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT stanislawskabiernatewa treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT takeuchitsutomu treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire AT vanderheijdedesiree treatingrheumatoidarthritistotargetmultinationalrecommendationsassessmentquestionnaire |